About The Study: Among adults age 60 years and older in 19 U.S. states, respiratory syncytial virus (RSV) vaccination was associated with a reduced likelihood of hospitalization with RSV compared with no vaccination. These findings expand upon prelicensure trial results in 2 ways. First, they provide evidence of vaccine protection against RSV-associated hospitalization, of which an estimated 60,000 to 160,000 occur annually among U.S. adults age 65 years and older. Second, they demonstrate protection in a population that more closely represents those at high risk of severe RSV disease, including adults age 75 years and older and those with immunocompromising conditions.
About The Study: Among adults age 60 years and older in 19 U.S. states, respiratory syncytial virus (RSV) vaccination was associated with a reduced likelihood of hospitalization with RSV compared with no vaccination. These findings expand upon prelicensure trial results in 2 ways. First, they provide evidence of vaccine protection against RSV-associated hospitalization, of which an estimated 60,000 to 160,000 occur annually among U.S. adults age 65 years and older. Second, they demonstrate protection in a population that more closely represents those at high risk of severe RSV disease, including adults age 75 years and older and those with immunocompromising conditions.
Corresponding Author: To contact the corresponding author, Diya Surie, MD, email dsurie@cdc.gov.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jama.2024.15775)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
Journal
JAMA
Cite Scienmag News
Kristina Jarvis. (September 4, 2024). RSV vaccine effectiveness against hospitalization among US adults 60 years and older. Scienmag. https://scienmag.com/rsv-vaccine-effectiveness-against-hospitalization-among-us-adults-60-years-and-older/
Kristina Jarvis. "RSV vaccine effectiveness against hospitalization among US adults 60 years and older." Scienmag, 4 September 2024, https://scienmag.com/rsv-vaccine-effectiveness-against-hospitalization-among-us-adults-60-years-and-older/. Accessed 3 September 2026.
Kristina Jarvis. "RSV vaccine effectiveness against hospitalization among US adults 60 years and older." Scienmag. September 4, 2024. https://scienmag.com/rsv-vaccine-effectiveness-against-hospitalization-among-us-adults-60-years-and-older/
